pergolide has been researched along with Depressive Disorder in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burlon, M; Göhring, K; Gruschka, P; Kaiser, S; Pfüller, U; Roesch-Ely, D; Weisbrod, M | 1 |
| Bernardi, S; Meco, G | 1 |
| Burn, DJ; Cartlidge, NE; Chinnery, PF; Cleland, PG; McKeith, I | 1 |
| Mattes, JA | 1 |
| Graham, JM; Grünewald, RA; Sagar, HJ | 1 |
| Masson, C | 1 |
| Kando, JC; Keck, PE; Wood, PA | 1 |
| Bernstein, J; Buckman, MT; Kellner, R; Mattox, JH; Pathak, D | 1 |
1 trial(s) available for pergolide and Depressive Disorder
| Article | Year |
|---|---|
Pergolide to augment the effectiveness of antidepressants: clinical experience and a small double-blind study.
Topics: Adjuvants, Pharmaceutic; Adult; Antidepressive Agents; Depressive Disorder; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Pergolide; Treatment Outcome | 1997 |
7 other study(ies) available for pergolide and Depressive Disorder
| Article | Year |
|---|---|
Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Comorbidity; Depressive Disorder; Dopamine Agonists; Drug Therapy, Combination; Frontal Lobe; Hallucinations; Humans; Male; Neural Pathways; Pergolide; Psychiatric Status Rating Scales; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia, Paranoid; Sulpiride; Treatment Outcome | 2006 |
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Clomipramine; Clozapine; Delusions; Depressive Disorder; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders | 2007 |
Management of parkinsonism and psychotic depression in a case of acute intermittent porphyria.
Topics: Antiparkinson Agents; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Middle Aged; Parkinson Disease, Secondary; Pergolide; Porphyria, Acute Intermittent; Psychotic Disorders | 1997 |
Hallucinosis in idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors | 1997 |
[Parkinson's disease].
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors | 2001 |
Pergolide-induced hypotension.
Topics: Depressive Disorder; Humans; Hypotension; Male; Middle Aged; Pergolide | 1990 |
Dopamine agonists for reducing depression associated with hyperprolactinemia.
Topics: Analysis of Variance; Bromocriptine; Depression; Depressive Disorder; Drug Evaluation; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin | 1986 |